Promising Antimicrobial Properties of Bioactive Compounds from Different Honeybee Products

Bee products have been known for centuries for their versatile healing properties. In recent decades they have become the subject of documented scientific research. This review aims to present and compare the impact of bee products and their components as antimicrobial agents. Honey, propolis, royal...

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 26; no. 13; p. 4007
Main Authors Ratajczak, Magdalena, Kaminska, Dorota, Matuszewska, Eliza, Hołderna-Kedzia, Elżbieta, Rogacki, Jarosław, Matysiak, Jan
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 30.06.2021
MDPI
Subjects
Acids
Antibiotics
antimicrobial activity
Antimicrobial agents
Bacteria
bee venom
Bees
Cancer
Egyptian civilization
Flavonoids
Glucose
Gram-negative bacteria
Honey
honeybee products
Microorganisms
propolis
Review
royal jelly
Skin
Skin diseases
Staphylococcus infections
New Zealand
Egypt
Online AccessGet full text

Cover

More Information
Summary:Bee products have been known for centuries for their versatile healing properties. In recent decades they have become the subject of documented scientific research. This review aims to present and compare the impact of bee products and their components as antimicrobial agents. Honey, propolis, royal jelly and bee venom are bee products that have antibacterial properties. Sensitivity of bacteria to these products varies considerably between products and varieties of the same product depending on their origin. According to the type of bee product, different degrees of activity were observed against Gram-positive and Gram-negative bacteria, yeasts, molds and dermatophytes, as well as biofilm-forming microorganisms. Pseudomonas aeruginosa turned out to be the most resistant to bee products. An analysis of average minimum inhibitory concentration values for bee products showed that bee venom has the strongest bacterial effectiveness, while royal jelly showed the weakest antibacterial activity. The most challenging problems associated with using bee products for medical purposes are dosage and safety. The complexity and variability in composition of these products raise the need for their standardization before safe and predictable clinical uses can be achieved.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
These authors contributed equally to this work.
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules26134007